These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 15721857

  • 1. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
    Abdelrahman M, Sivarajah A, Thiemermann C.
    Cardiovasc Res; 2005 Mar 01; 65(4):772-81. PubMed ID: 15721857
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
    Belvisi MG, Hele DJ, Birrell MA.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):101-9. PubMed ID: 16458290
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury.
    Cuzzocrea S.
    Vascul Pharmacol; 2004 Jul 08; 41(6):187-95. PubMed ID: 15653094
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion.
    Collino M, Aragno M, Mastrocola R, Gallicchio M, Rosa AC, Dianzani C, Danni O, Thiemermann C, Fantozzi R.
    Eur J Pharmacol; 2006 Jan 13; 530(1-2):70-80. PubMed ID: 16386242
    [Abstract] [Full Text] [Related]

  • 7. PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury.
    Collino M, Patel NS, Thiemermann C.
    Ther Adv Cardiovasc Dis; 2008 Jun 13; 2(3):179-97. PubMed ID: 19124421
    [Abstract] [Full Text] [Related]

  • 8. Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice.
    Akahori T, Sho M, Hamada K, Suzaki Y, Kuzumoto Y, Nomi T, Nakamura S, Enomoto K, Kanehiro H, Nakajima Y.
    J Hepatol; 2007 Dec 13; 47(6):784-92. PubMed ID: 17936399
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptors and acute lung injury.
    Cuzzocrea S.
    Curr Opin Pharmacol; 2006 Jun 13; 6(3):263-70. PubMed ID: 16580256
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y, Yin W, Signore AP, Zhang F, Hong Z, Wang S, Graham SH, Chen J.
    J Neurochem; 2006 Apr 13; 97(2):435-48. PubMed ID: 16539667
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders.
    Honda T, Kaikita K, Tsujita K, Hayasaki T, Matsukawa M, Fuchigami S, Sugiyama S, Sakashita N, Ogawa H, Takeya M.
    J Mol Cell Cardiol; 2008 May 13; 44(5):915-26. PubMed ID: 18436235
    [Abstract] [Full Text] [Related]

  • 13. Rosiglitazone reduces the inflammatory response in a model of vascular injury in rats.
    Rinaldi B, Pieri L, Donniacuo M, Cappetta D, Capuano A, Domenici L, Carnuccio R, Romagnoli P, Filippelli A, Rossi F.
    Shock; 2009 Dec 13; 32(6):638-44. PubMed ID: 19333142
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?
    Feinstein DL, Spagnolo A, Akar C, Weinberg G, Murphy P, Gavrilyuk V, Dello Russo C.
    Biochem Pharmacol; 2005 Jul 15; 70(2):177-88. PubMed ID: 15925327
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptor gamma in malignant diseases.
    Wang T, Xu J, Yu X, Yang R, Han ZC.
    Crit Rev Oncol Hematol; 2006 Apr 15; 58(1):1-14. PubMed ID: 16388966
    [Abstract] [Full Text] [Related]

  • 17. PPAR and Pain.
    Maeda T, Kishioka S.
    Int Rev Neurobiol; 2009 Apr 15; 85():165-77. PubMed ID: 19607969
    [Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
    Duan SZ, Usher MG, Mortensen RM.
    Circ Res; 2008 Feb 15; 102(3):283-94. PubMed ID: 18276926
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.
    Bernardo A, Bianchi D, Magnaghi V, Minghetti L.
    J Neuropathol Exp Neurol; 2009 Jul 15; 68(7):797-808. PubMed ID: 19535992
    [Abstract] [Full Text] [Related]

  • 20. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats.
    Park SW, Yi JH, Miranpuri G, Satriotomo I, Bowen K, Resnick DK, Vemuganti R.
    J Pharmacol Exp Ther; 2007 Mar 15; 320(3):1002-12. PubMed ID: 17167171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.